[1]Friedenstein AJ, Piatetzky-Shapiro II, Petrakova KV.Osteogenesis in transplants of bone-marrow cells[J].J Embryol Exp Morphol, 1966, 16:381-390. [2]Friedenstein AJ, Gorskaja JF, Kulagina NN.Fibroblast precursors in normal and irradiated mouse hematopoietic organs[J].Exp Hematol, 1976, 4(5):267-274. [3]Owen M, Friedenstein AJ.Stromal stem cells:marrow-derived osteogenic precursors[J].Ciba Found Symp, 1988, 136:42-60. [4]Caplan AI.Mesenchymal stem cells[J].J Orthop Res, 1991, 9:641-650. [5]Ahn MY, Zhang ZG, Tsang W, et al.Endogenous plasminogen activator expression after embolicfocal cerebral ischemia in mice[J].Brain Res, 1999, 83(7):169-176. [6]Campagnoli C, Roberts IA, Kumar S, et al.Identification of mesenchymal stem/progenitorcells in human first-trimester fetal blood, liver, and bone marrow[J].Blood, 2001, 98:2396-2402. [7]Zvaifler NJ, Marinova-Mutafchieva L, Adams G, et al.Mesenchymal precursor cells in theblood of normal individuals[J].Arthritis Res, 2000, 2:477-488. [8]Erices A, Conget P, Minguell JJ.Mesenchymal progenitor cells in human umbilical cord blood[J].Br J Haematol, 2000, 109:235-242. [9]Wang HS, Hung SC, Peng ST, et al.Mesenchymal stem cells in the Wharton’s jelly of thehuman umbilical cord[J].Stem Cells, 2004, 22:1330-1337. [10]In ‘t Anker PS, Scherjon SA, Kleijburg-van der Keur C, et al.Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta[J].Stem Cells, 2004, 22:1338-1345. [11]Bruder SP, Kurth AA, Shea M, et al.Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells[J].J Orthop Res, 1998, 16:155-162. [12]Shur I, Lokiec F, Bleiberg I, et al.Differential gene expression of cultured human osteoblasts[J].J Cell Biochem, 2001, 83:547-553. [13]Solmesky L, Lefler S, Jacob-Hirsch J, et al.Serum free cultured bone marrow mesenchymal stem cells as a platform to characterize the effects of specific molecules[J].PLoS One, 2010, 5(9):e12689. [14]Sotiropoulou PA, Perez SA, Salagianni M, et al.Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells[J].Stem Cells, 2006, 24:462-471. [15] Horwitz E, Le BK, Dominici M, et al.Clarification of the nomenclature for MSC:the international society for cellular therapy position statement[J].Cytotherapy, 2005, 7:393-395. [16]Dominici M, Le Blanc K, Mueller I, et al.Minimal criteria for defining multipotent mesenchymal stromal cells.the international society for cellular therapy position statement[J].Cytotherapy, 2006, 8:315-317. [17] Burgener A.Cell culture technology for pharmaceutical and cell-based therapies[M].USA:CRC Press, 2006:41-79. [18]Ren Y, Wu H, Wang X, et al.Analysis of the stem cell characteristics of adult stem cells from Arbas white Cashmere goat[J].Biochemical, 2014, 448(2):121-128. [19]Ren Y, Wu H, Wang X, et al.The effect of arbas cashmere goat bone marrow stromal cells on production of transgenic cloned embryos[J].Theriogenology, 2014, 81(9):1257-1267. [20]Rosen ED, Spiegelman BM.PPARγ:a nuclear regulator of metabolism, differentiation, and cell growth[J].J Bio Chem, 2001, 276(41):37731-37734. [21] Tontonoz P, Hu E, Graves RA, et al.PPAR γ2:tissue-specific regulator of an adipocyte enhancer[J].Genes Dev, 1994, 8:1224-1234. [22] Ryoo HM, Hoffmann HM, Beumer T, et al.Stage-specific expression of dlx-5 during osteoblast differentiation:involvement in regulation of osteocalcin gene expression[J].Mol Endocrinol, 1997, 11(11):1681-1694. [23]Hauschka PV, Lian JB, Cole DE, et al.Osteocalcin and matrix gla protein vitamin K-dependent proteins in bone[J].Physiol Rev, 1989, 69(3):990-1047. [24]A?il Y, Ghoniem AA, Wiltfang J.Optimizing the osteogenic differentiation of human mesenchymal stromal cells by the synergistic action of growth factors[J].J Craniomaxillofac Surg, 2014, 42(8):2002-2009. [25]Pietraszek K, Chatron-Colliet A, Brezillon S, et al.Lumican:A new inhibitor of matrix metalloproteinase-14 activity[J].FEBS Lett, 2014, 588(23):4319-4324. |